Consultation News and Research

RSS

Science and precedent do not support biosimilar approach for plasma protein therapies

The current science and experience does not support the safety and efficaciousness of a biosimilar pathway for plasma protein therapies. At a public hearing last week, the Plasma Protein Therapeutics Association (PPTA) urged the United States Food and Drug Administration (FDA) to make patient safety its top priority by adopting a global approach in its evaluation of plasma protein therapies for the biosimilars process.

15 Nov 2010

Five Grand Challenges for Earth system

The international scientific community has identified five Grand Challenges that, if addressed in the next decade, will deliver knowledge to enable sustainable development, poverty eradication, and environmental protection in the face of global change. The Grand Challenges for Earth system science, published today, are the result of broad consultation as part of a visioning process spearheaded by the International Council for Science (ICSU) in cooperation with the International Social Science Council (ISSC).

12 Nov 2010

Elsevier partners with APM to publish Psychosomatic journal

Elsevier, the world's leading publisher of scientific, technical and medical information, announced today that it is partnering with the Academy of Psychosomatic Medicine (APM) to publish Psychosomatics, the official journal of the Academy of Psychosomatic Medicine.

10 Nov 2010

Zalicus third quarter total revenue decreases to $1.2 million

"We made solid product development progress this quarter," commented Mark H.N. Corrigan, MD, President and CEO of Zalicus. "We finalized our development plans for Synavive, and also related to Synavive, we were awarded a Therapeutic Discovery Project grant to help fund Synavive development going forward.

10 Nov 2010

Health advice on NHS website saves £44 million per year

The latest study has shown that as more people self diagnose using the NHS Choices website, Britain’s national healthcare service saves millions of pounds every year. The website was launched three years ago. Last year more than 100 million visits were recorded at the site which offers patients a quick reference guide to illnesses, symptoms, diagnosis and treatment. Overall, there was a 10% increase in the number of visits to the website in 2010 compared to 2009. Some 19 million people logged on to NHS Choices for information on swine flu.

9 Nov 2010

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and a financial update for the third quarter ended September 30, 2010.

9 Nov 2010

Sec. Clinton highlights importance of U.S.-Australia partnership to reduce violence against women worldwide

As part of her two-week Asia-Pacific tour, Secretary of State Hillary Rodham Clinton was in Australia on Saturday, where she called for increased cooperation between Australia and the U.S. to help drive down violence against women globally, Bloomberg reports.

9 Nov 2010

Bio-Path awarded $244,479 federal grant for Liposomal Grb-2 Phase I clinical trial

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has received a grant of $244,479 from the United States Government to help fund the Company's Phase I clinical trial of its lead cancer drug candidate Liposomal Grb-2. The amount of funds awarded was the maximum allocation allowed under the program.

4 Nov 2010

Immense potential for digitized personal health records in chronic disease management

Faster and more widely available internet access has improved our lives in many ways but healthcare is lagging behind, according to researchers writing in the International Journal of Medical Engineering and Informatics.

3 Nov 2010

Illumina, Expression Analysis support Cancer GWAS and Data Analysis Grant program

Expression Analysis today announced that it and Illumina, Inc. are jointly funding a Cancer GWAS (Genome-Wide Association Study) and Data Analysis Grant program to support cutting-edge projects that show promise in identifying genetic elements important to cancer research and treatment.

From Illumina, Inc. 3 Nov 2010

Fresenius third quarter net revenue increases 6% to $3,058 million

Fresenius Medical Care AG & Co. KGaA: Net revenue for the third quarter of 2010 increased by 6% to $3,058 million compared to the third quarter of 2009. Organic revenue growth worldwide was 6%.

2 Nov 2010

Alcohol - the worst drug!

A new study shows that alcohol abuse is by far the worst habit to have when compared to other recreational drugs like crack or heroin. Neuropharmacologist David Nutt, of Imperial College London who is also a former British government drug advisor and his team rated 20 different drugs on a scale that takes into account the various harms caused by a drug. Drugs are rated on the nine harms a drug causes to an individual and seven harms a drug causes to the society. The scale was developed by a panel of experts called the Independent Scientific Committee on Drugs (ICSD), ranges from 0 (no harm) to 100 (greatest possible harm). It is weighted so that a drug that scores 50 is half as harmful as a drug that scores 100.

1 Nov 2010

Progress update on Johnson & Johnson and Crucell's public offer

Pursuant to the provisions of Section 7 paragraph 1(a) of the Dutch Decree on Public Takeover Bids (Besluit Openbare Biedingen Wft) requiring a public announcement within four weeks following the announcement of an intended public offer to provide a status update, Johnson & Johnson (NYSE: JNJ) and Crucell N.V. provide the following joint update.

30 Oct 2010

Caraco third quarter net sales increases from $78.4 million to $97.8 million

Caraco Pharmaceutical Laboratories, Ltd. generated net sales of $97.8 million and $227.8 million during the second quarter ended September 30, 2010 and first six months of the Company's current fiscal year ended September 30, 2010, respectively, as compared to $78.4 million and $126.4 million, respectively, for the corresponding periods of the previous fiscal year ended September 30, 2009.

30 Oct 2010

Pepsi Refresh grant helps in launching Rett syndrome drug development program

The International Rett Syndrome Foundation (IRSF) believes that accelerating the pace of meritorious research, supporting families, and raising awareness are the minimum effort necessary to successfully search for treatments and a cure for one of the most devastating neurological diseases to affect young girls. On October 1, IRSF became the recipient of a $250,000 grant from the Pepsi Refresh contest that was officially confirmed later in the month.

29 Oct 2010

UNC awards Doctorate degree to Premier Research biostatistician

Premier Research Group Limited, an international CRO with considerable oncology research expertise, is pleased to announce that Dr. Liddy Chen has received a Doctorate degree in Biostatistics, focusing on study design issues in advanced survival models with major application to oncology clinical trials, from University of North Carolina at Chapel Hill.

28 Oct 2010

Omnyx initiates research testing of digital pathology platform

GE Healthcare and UPMC announced today that their imaging joint venture, Omnyx, is initiating clinical research testing of a breakthrough digital pathology platform that is expected to help transform the 125-year-old practice of pathologists using glass slides.

28 Oct 2010

New technologies streamline health IT system; Electronic medical records raise privacy issues

The Associated Press: Although many healthcare providers are making the jump to computerized medical records, an "e-chart stored in one doctor's computer too often can't be read by another's across town." Surescripts, "the country's largest network for paperless prescribing," is expanding "so that doctors around the country can choose to share medical reports, X-rays and other health data over its network much as they send e-prescriptions to drugstores today, regardless of what competing brand of computerized health records they use."

27 Oct 2010

Challenges in overcoming communication barriers when treating non-Swedish-speaking patients

The healthcare system faces a challenge in overcoming communication barriers when treating non-Swedish-speaking patients, reveals a thesis from the University of Gothenburg, Sweden.

26 Oct 2010

FDA warns about risk of Hyland's Teething Tablets to children

The U.S. Food and Drug Administration today is warning consumers that Hyland's Teething Tablets may pose a risk to children. The FDA recommends that consumers not use this product and dispose of any in their possession. The manufacturer is issuing a recall of this product.

25 Oct 2010

Consultation News and Research

Science and precedent do not support biosimilar approach for plasma protein therapies

Five Grand Challenges for Earth system

Elsevier partners with APM to publish Psychosomatic journal

Zalicus third quarter total revenue decreases to $1.2 million

Health advice on NHS website saves £44 million per year

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Sec. Clinton highlights importance of U.S.-Australia partnership to reduce violence against women worldwide

Bio-Path awarded $244,479 federal grant for Liposomal Grb-2 Phase I clinical trial

Immense potential for digitized personal health records in chronic disease management

Illumina, Expression Analysis support Cancer GWAS and Data Analysis Grant program

Fresenius third quarter net revenue increases 6% to $3,058 million

Alcohol - the worst drug!

Progress update on Johnson & Johnson and Crucell's public offer

Caraco third quarter net sales increases from $78.4 million to $97.8 million

Pepsi Refresh grant helps in launching Rett syndrome drug development program

UNC awards Doctorate degree to Premier Research biostatistician

Omnyx initiates research testing of digital pathology platform

New technologies streamline health IT system; Electronic medical records raise privacy issues

Challenges in overcoming communication barriers when treating non-Swedish-speaking patients

FDA warns about risk of Hyland's Teething Tablets to children

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News